BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Business

  Money on the Move: October 20 – 26

  While the volatility of the market has some shying away from going public, private investment dollars are still rolling in each week. Check out our top picks.

  October 27, 2021

   · 

  4 min read

   · 

  Kate Goodwin
• 

  Pharm Country

  Immunai Scores $215 Million to Accelerate Mapping of the Immune System

  The growth includes the tripling of its headcount to 120 employees and more than 30 partnerships with leading universities and institutions.

  October 27, 2021

   · 

  4 min read

   · 

  Alex Keown
• 

  Drug Development

  Angion and Vifor Disappointed After Phase III Kidney Transplant Study Fails

  The clinical study on ANG-3777 demonstrated a modest but not clinically significant difference in the placebo group’s estimated glomerular filtration rate.

  October 27, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  Ocugen Hopes to Launch Phase III Trial of Covaxin in U.S.

  Pennsylvania-based Ocugen has submitted an Investigational New Drug (IND) to the FDA to run a Phase III trial of India’s BBV152 (Covaxin), a vaccine against COVID-19.

  October 27, 2021

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  Teva and MODAG Tie Up on Potential Parkinson’s, MSA Treatment

  Teva Pharmaceuticals inked a deal with MODAG GmbH to license and develop two of MODAG’s compounds in neurodegenerative disease, anle138b and sery433.

  October 27, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Policy

  Rep for Wealthy Theranos Stakeholder Describes Holmes’ Investor Courting Practice

  This week during the ongoing trial of Elizabeth Holmes, representatives from one wealthy family described the process with which Holmes secured private investments.

  October 27, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  Trial For World’s First Potential Breast Cancer Vaccine Begins

  A large number of people were waiting for the breast cancer vaccine. Now, at present, the world has witnessed the first potential vaccine. Let’s take a look at it.

  October 27, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Deals

  Elevate Bio Takes Gene Editing to Next Level with Life Edit Buy

  With the complete acquisition of Life Edit, ElevateBio will be able to integrate that company’s genome editing capabilities with its cell and gene therapies.

  October 27, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Eli Lilly and Pfizer Put Osteoarthritis Pain Drug Tanezumab Out of its Misery

  The osteoarthritis drug tanezumab gets permanent leave from the market. The decision of stopping production was due to negative feedback from the regulators.

  October 27, 2021

   · 

  2 min read

   · 

  Heather McKenzie
• 

  Global Roundup: Mallinckrodt Shares Real-World Data for Terlipressin

  Biopharma and life sciences companies from across the globe provide updates on their business and pipelines.

  October 27, 2021

   · 

  6 min read

   · 

  Alex Keown